Form 8-K - Current report:
SEC Accession No. 0001493152-25-003054
Filing Date
2025-01-21
Accepted
2025-01-21 16:30:15
Documents
15
Period of Report
2025-01-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 74881
2 ex10-1.htm EX-10.1 51597
3 ex10-2.htm EX-10.2 71762
  Complete submission text file 0001493152-25-003054.txt   409669

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE mgrx-20250115.xsd EX-101.SCH 3033
5 XBRL LABEL FILE mgrx-20250115_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE mgrx-20250115_pre.xml EX-101.PRE 24177
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3891
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 25542853
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)